6 things you need to know about Bladder Cancer | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Bladder cancer

June 2018

6 things you need to know about Bladder Cancer

  • Bladder cancer is the ninth most commonly diagnosed cancer in the world with an estimated 430 000 new cases reported in 2012.
  • Men are more than three times more likely to get bladder cancer than women.
  • Smoking is a major cause of bladder cancer.
  • Exposure to industrial chemicals such as metalworking fluids is another cause of bladder cancer.
  • One of the most common symptoms of bladder cancer is the presence of blood in urine.
  • Cystoscopy and urine cytology are the most common methods for detection and assessment of recurrence of bladder cancer. Cystoscopy may cause pain and discomfort in patients, and urine cytology has a low sensitivity.IDL Biotech has developed UBC Rapid, a complement to cystoscopy, which causes no pain for the patient. Read more about UBC Rapid here.

IDL Biotech förbereder kliniska studier i USA för sitt snabbtest för blåscancer, UBC® Rapid

Under 2019 lämnade IDL Biotech in underlag, en så kallad ”pre-submission request”, till amerikanska FDA (Food and Drug Administration) för att kunna få ett framtida godkännande av UBC® Rapid, bolagets snabbtest för blåscancer. Nu går bolaget vidare och förbereder kliniska studier i USA.

Business Development Manager Asia

IDL Biotech has appointed Subyung Park as Business Development Manager Asia with a focus on the product TUBEX® TF.

IDL Biotech

Skip this intro